FIRM FIXED PRICENO SET ASIDE USED.
ROCHE DIAGNOSTICS CORPORATION - COBAS TAQMAN HIV-1 TEST
PIID: 75N93021P01069Solicitation ID: NOI-RML-2085853
Signed Date: Feb 26, 2026Effective Date: Sep 15, 2021End Date: Closed on Jun 1, 2022
Key Details
Description
COBAS TAQMAN HIV-1 TEST
Contractor Information
Contractor: ROCHE DIAGNOSTICS CORPORATION
UEI: JDMDFEZBYH36
CAGE Code: 51169
Location: INDIANAPOLIS, IN
Similar Awards
DEVELOPMENT AND DOMESTIC MANUFACTURE OF ADJUVANTED, PANDEMIC INFLUENZA VACCINES
SANOFI VACCINES US INC.
$612.2M
OTHER TRANSACTION: PRODUCTION OF DRUG SUBSTANCES AND DRUG PRODUCTS AT COMMERCIAL SCALE UNDER BIOMAP-CONSORTIUM
ADVANCED TECHNOLOGY INTERNATIONAL
$304.0M
EXPANSION OF PRODUCTION CAPACITY OF MAN-MADE FABRIC FOR MANUFACTURING DISPOSABLE MEDICAL GOWNS
ADVANCED TECHNOLOGY INTERNATIONAL
$248.5M
OTHER TRANSACTION: PROCUREMENT AND SUSTAINMENT OF N95 MASK MANUFACTURING CAPACITY UNDER THE BIOMAP-CONSORTIUM.
ADVANCED TECHNOLOGY INTERNATIONAL
$141.3M
EXPANSION OF DOMESTIC MANUFACTURING CAPACITY FOR NITRILE GLOVES
ADVANCED TECHNOLOGY INTERNATIONAL
$61.0M
Stay Updated
Get notified about new opportunities matching your interests.